The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Nanoparticles: Health Effects—Pros and Cons
Open accessAbstract
With the advent of nanotechnology, the prospects for using engineered nanomaterials with diameters of < 100 nm in industrial applications, medical imaging, disease diagnoses, drug delivery, cancer treatment, gene therapy, and other areas have progressed rapidly. The potential for nanoparticles (NPs) in these areas is infinite, with novel new applications constantly being explored. The possible toxic health effects of these NPs associated with human exposure are unknown. Many fine particles generally considered "nuisance dusts" are likely to acquire unique surface properties when engineered to nanosize and may exhibit toxic biological effects. Consequently, the nuisance dust may be transported to distant sites and could induce adverse health effects. In addition the beneficial uses of NPs in drug delivery, cancer treatment, and gene therapy may cause unintentional human exposure. Because of our lack of knowledge about the health effects associated with NP exposure, we have an ethical duty to take precautionary measures regarding their use. In this review we highlight the possible toxic human health effects that can result from exposure to ultrafine particles (UFPs) generated by anthropogenic activities and their cardiopulmonary outcomes. The comparability of engineered NPs to UFPs suggests that the human health effects are likely to be similar. Therefore, it is prudent to elucidate their toxicologic effect to minimize occupational and environmental exposure. Highlighting the human health outcomes caused by UFPs is not intended to give a lesser importance to either the unprecedented technologic and industrial rewards of the nanotechnology or their beneficial human uses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Semiconductor Nanocrystals as Fluorescent Biological Labels
Bruchez, M., Moronne, M., Gin, P., Weiss, S., & Alivisatos, A. P. (1998) · Science · doi:10.1126/science.281.5385.2013 · Cited by 8,613
An association between air pollution and mortality in six U.S. cities
Dockery, D. W., Pope, C. A., Xu, X., Spengler, J. D., Ware, J. H., Fay, M. E., Ferris, B. G., & Speizer, F. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312093292401 · Cited by 8,018
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,772
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults.
Pope, C. A., Thun, M. J., Namboodiri, M. M., Dockery, D. W., Evans, J. S., Speizer, F. E., & Heath, C. W. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.3.7881654 · Cited by 2,911
Fine Particulate Air Pollution and Hospital Admission for Cardiovascular and Respiratory Diseases
Dominici, F., Peng, R. D., Bell, M. L., Pham, L., McDermott, A., Zeger, S. L., & Samet, J. M. (2006) · JAMA · doi:10.1001/jama.295.10.1127 · Cited by 2,634
Translocation of inhaled ultrafine particles to the brain
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., & Cox, C. (2004) · Inhalation Toxicology · doi:10.1080/08958370490439597 · Cited by 2,606
Pope, C. A., Burnett, R. T., Thurston, G. D., Thun, M. J., Calle, E. E., Krewski, D., & Godleski, J. J. (2004) · Circulation · doi:10.1161/01.cir.0000108927.80044.7f · Cited by 2,592
Cited by
Silver nanoparticles: Green synthesis and their antimicrobial activities
Sharma, V. K., Yngard, R. A., & Lin, Y. (2009) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2008.09.002 · Cited by 3,900
The golden age: gold nanoparticles for biomedicine
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El-Sayed, M. A. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15237h · Cited by 3,550
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Toxicity Testing in the 21st Century: A Vision and a Strategy
Krewski, D., Acosta, D., Andersen, M., Anderson, H., Bailar, J. C., Boekelheide, K., Brent, R., Charnley, G., Cheung, V. G., Green, S., et al. (2010) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2010.483176 · Cited by 1,688
Nanoparticles in cellular drug delivery
Faraji, A. H., & Wipf, P. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.02.043 · Cited by 903
Xuan, L., Ju, Z., Skonieczna, M., Zhou, P., & Huang, R. (2023) · MedComm · doi:10.1002/mco2.327 · Cited by 807
Fadeel, B., & Garcia-Bennett, A. E. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.008 · Cited by 783
Toxicity Assessments of Multisized Gold and Silver Nanoparticles in Zebrafish Embryos
Bar‐Ilan, O., Albrecht, R. M., Fako, V. E., & Furgeson, D. Y. (2009) · Small · doi:10.1002/smll.200801716 · Cited by 648
Safe Nanoparticles: Are We There Yet?
Najahi-Missaoui, W., Arnold, R. D., & Cummings, B. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010385 · Cited by 581
Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes
Rudramurthy, G., Swamy, M., Sinniah, U., & Ghasemzadeh, A. (2016) · Molecules · doi:10.3390/molecules21070836 · Cited by 556
Santhoshkumar, T., Rahuman, A. A., Jayaseelan, C., Rajakumar, G., Marimuthu, S., Kirthi, A. V., Velayutham, K., Thomas, J., Venkatesan, J., & Kim, S.-K. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60171-1 · Cited by 531
Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress
Naqvi, Naqvi, Samim, M., Abdin, M. Z., Ahmad, F. J., prashant, C. K., & Dinda, A. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s13244 · Cited by 474
RetractedBiodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials
Bourquin, J., Milosevic, A., Hauser, D., Lehner, R., Blank, F., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2018) · Advanced Materials · doi:10.1002/adma.201704307 · Cited by 461
Taurozzi, J. S., Hackley, V. A., & Wiesner, M. R. (2011) · Nanotoxicology · doi:10.3109/17435390.2010.528846 · Cited by 460
Necrotic, apoptotic and autophagic cell fates triggered by nanoparticles
Mohammadinejad, R., Moosavi, M. A., Tavakol, S., Vardar, D. Ö., Hosseini, A., Rahmati, M., Dini, L., Hussain, S., Mandegary, A., & Klionsky, D. J. (2019) · Autophagy · doi:10.1080/15548627.2018.1509171 · Cited by 453
Apopa, P. L., Qian, Y., Shao, R., Guo, N. L., Schwegler-Berry, D., Pacurari, M., Porter, D., Shi, X., Vallyathan, V., Castranova, V., et al. (2009) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-6-1 · Cited by 445
Self-citationCarbon nanotubes: a novel material for multifaceted applications in human healthcare
Kumar, S., Rani, R., Dilbaghi, N., Tankeshwar, K., & Kim, K.-H. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00517a · Cited by 397
Functionalized carbon nanotubes for potential medicinal applications
Zhang, Y., Bai, Y., & Yan, B. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.04.005 · Cited by 396
Pacurari, M., Yin, X. J., Zhao, J., Ding, M., Leonard, S. S., Schwegler-Berry, D., Ducatman, B. S., Sbarra, D., Hoover, M. D., Castranova, V., et al. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.10924 · Cited by 372
Self-citationJacobsen, N. R., Pojana, G., White, P., Møller, P., Cohn, C. A., Smith Korsholm, K., Vogel, U., Marcomini, A., Loft, S., & Wallin, H. (2008) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20406 · Cited by 370
Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation
Choi, H. S., & Frangioni, J. V. (2010) · Molecular Imaging · doi:10.2310/7290.2010.00031 · Cited by 351
Toxicity of metal-based nanoparticles: Challenges in the nano era
Zhang, N., Xiong, G., & Liu, Z. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1001572 · Cited by 343
A comparison of nanoparticle and fine particle uptake by Daphnia magna
Rosenkranz, P., Chaudhry, Q., Stone, V., & Fernandes, T. F. (2009) · Environmental Toxicology and Chemistry · doi:10.1897/08-559.1 · Cited by 331
Garner, K. L., & Keller, A. A. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2503-2 · Cited by 330
Bioavailability of silver nanoparticles and ions: from a chemical and biochemical perspective
Behra, R., Sigg, L., Clift, M. J. D., Herzog, F., Minghetti, M., Johnston, B., Petri-Fink, A., & Rothen-Rutishauser, B. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0396 · Cited by 328
Clinical toxicities of nanocarrier systems.
Vega-Villa, K. R., Takemoto, J. K., Yáñez, J. A., Remsberg, C. M., Forrest, M. L., & Davies, N. M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.007 · Cited by 325
“Nanotechnology is expected to become a trilliondollar industry by 2015 [3,41].”
BackgroundPaur, H.-R., Cassee, F. R., Teeguarden, J., Fissan, H., Diabate, S., Aufderheide, M., Kreyling, W. G., Hänninen, O., Kasper, G., Riediker, M., et al. (2011) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2011.06.005 · Cited by 316
Biocompatibility of Mesoporous Silica Nanoparticles?
Shi, Y., Miller, M. L., & Di Pasqua, A. J. (2016) · Comments on Inorganic Chemistry · doi:10.1080/02603594.2015.1088439 · Cited by 315
Fenoglio, I., Greco, G., Tomatis, M., Muller, J., Raymundo-Piñero, E., Béguin, F., Fonseca, A., Nagy, J. B., Lison, D., & Fubini, B. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800100s · Cited by 302
Nanoparticle dermal absorption and toxicity: a review of the literature
Crosera, M., Bovenzi, M., Maina, G., Adami, G., Zanette, C., Florio, C., & Filon Larese, F. (2009) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-009-0458-x · Cited by 297
Nanoparticles and Neurotoxicity
Win-Shwe, T.-T., & Fujimaki, H. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12096267 · Cited by 296
Multifunctional nanoparticles: Analytical prospects
de Dios, A. S., & Díaz-García, M. E. (2010) · Analytica Chimica Acta · doi:10.1016/j.aca.2010.03.038 · Cited by 290
Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction
Nurkiewicz, T. R., Porter, D. W., Hubbs, A. F., Cumpston, J. L., Chen, B. T., Frazer, D. G., & Castranova, V. (2008) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-5-1 · Cited by 281
Nemmar, A., Holme, J. A., Rosas, I., Schwarze, P. E., & Alfaro-Moreno, E. (2013) · BioMed Research International · doi:10.1155/2013/279371 · Cited by 278
Lu, S., Duffin, R., Poland, C., Daly, P., Murphy, F., Drost, E., MacNee, W., Stone, V., & Donaldson, K. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.11811 · Cited by 274
Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats
Tiwari, D. K., Jin, T., & Behari, J. (2011) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2010.529184 · Cited by 272
Nanodiamond–insulin complexes as pH-dependent protein delivery vehicles
Shimkunas, R. A., Robinson, E., Lam, R., Lu, S., Xu, X., Zhang, X.-Q., Huang, H., Osawa, E., & Ho, D. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.004 · Cited by 267
Logue, J. M., McKone, T. E., Sherman, M. H., & Singer, B. C. (2011) · Indoor Air · doi:10.1111/j.1600-0668.2010.00683.x · Cited by 266
Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity
Fako, V. E., & Furgeson, D. Y. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.008 · Cited by 261
Number size distributions and seasonality of submicron particles in Europe 2008–2009
Asmi, A., Wiedensohler, A., Laj, P., Fjaeraa, A.-M., Sellegri, K., Birmili, W., Weingartner, E., Baltensperger, U., Zdimal, V., Zikova, N., et al. (2011) · Atmospheric Chemistry and Physics · doi:10.5194/acp-11-5505-2011 · Cited by 257
Toxicity and Developmental Defects of Different Sizes and Shape Nickel Nanoparticles in Zebrafish
Ispas, C., Andreescu, D., Patel, A., Goia, D. V., Andreescu, S., & Wallace, K. N. (2009) · Environmental Science & Technology · doi:10.1021/es9010543 · Cited by 254
Nakane, H. (2012) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-011-0252-8 · Cited by 101
Geiser, M., Quaile, O., Wenk, A., Wigge, C., Eigeldinger-Berthou, S., Hirn, S., Schäffler, M., Schleh, C., Möller, W., Mall, M. A., et al. (2013) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-10-19 · Cited by 97
Alternative strategies in cardiac preclinical research and new clinical trial formats
Kreutzer, F. P., Meinecke, A., Schmidt, K., Fiedler, J., & Thum, T. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab075 · Cited by 36
(2008) · doi:10.1061/(asce)0893-1321(2008)21:4(266
(2008) · doi:10.1061/(asce)0893-1321(2008)21:4(272
Metadata
- Authors
- Gwinn, M. R., & Vallyathan, V.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-12
- Volume
- 114
- Issue
- 12
- Pages
- 1818-1825
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2107205997
- Cited by
- 571
- References
- 89
- FWCI
- 25.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.